Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Salt form disclosure
A landmark review by Pickart and Margolina in Biomolecules confirming GHK-Cus broad gene regulatory influence on tissue repair pathways supports its complementary role alongside metabolic interventions like NAD+ therapy
Catalase (EC 1.11.1.6) was assayed by measuring the disappearance of H 2 O 2 84
Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each Subcutaneous doses are much smaller than oral doses because of injection volume limits and because direct subQ absorption skips the gut
The aim is to quickly fill up Vitamin B12 stores and ease symptoms
Auf einen Blick: Kupferpeptide (GHK-Cu) GHK-Cu ist ein natrlich vorkommendes Kupferpeptid, das in der Hautpflege vor allem mit Regeneration, Hautschutz und Hautstruktur in Verbindung gebracht wird
US$ 29.81
US$ 27.83
US$ 23.42
US$ 24.87
US$ 29.06
